Prophylactic therapy of migraine in primary care

Headache Quarterly

Volumn 7, Issue SUPPL. 1, 1996, Pages 6-12

  Cady, Roger K ^a  

^a HEADACHE CARE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYPROHEPTADINE; DILTIAZEM; METHYLERGOMETRINE; METHYLERGOMETRINE MALEATE; METHYSERGIDE; METHYSERGIDE MALEATE; MONOAMINE OXIDASE INHIBITOR; NIFEDIPINE; NONSTEROID ANTIINFLAMMATORY AGENT; PHENELZINE; PROPRANOLOL; SEROTONIN ANTAGONIST; TIMOLOL; TIMOLOL MALEATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM; VERAPAMIL;

ANTICHOLINERGIC EFFECT; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; FEEDBACK SYSTEM; GASTROINTESTINAL TOXICITY; HUMAN; IMPOTENCE; LETHARGY; MIGRAINE; MYALGIA; NEPHROTOXICITY; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; SOMNOLENCE;

EID: 0029775831     PISSN: 10597565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Amery WK. Prophylactic and curative treatment of migraine with calcium antagonists. Drug Des Deliv. 1989; 4:197-203.
2. Baischer W. Acupuncture in migraine: Long-term outcome and predicting factors. Headache. 1995; 35:472-474.
3. Blanchard EB, Appelbaum KA, Radnitz CL. A controlled evaluation of thermal biofeedback and thermal biofeedback combined with cognitive therapy in the treatment of vascular headache. J Consult Clin Psych. 1990; 58:216-224.
4. Couch JR, Ziegler DK, Hassanein RS. Amitriptyline in migraine prophylaxis. Arch Neurol. 1979; 36:695-699.
5. Hering R, Kuritzky. Sodium valproate in the prophylactic treatment of migraine: A double-blind study versus placebo. Cephalalgia. 1992; 12:81-84.
6. Jensen R, Brinck T, Olesen J: Sodium valproate has a prophylactic effect in migraine without aura. Neurology. 1994; 44:647-651.
7. Martin PR, Marie GV, Nathan PR. Behavioral research on headaches: A coded bibliography. Headache. 1987; 27:555-570.
8. Mathew NT, Reuveni U, Perez F. Transformed or evolutive migraine. Headache. 1987; 27:102-106.
9. _Kurman R, Perez F. Drug-induced refractory headache: Clinical features and management. Headache. 1990; 30:634-638.
10. _Saper JR, Silberstein SD, Rankin L, Markley HG, Solomon S, et al. Migraine prophylaxis with divalproex. Arch Neurol. 1995; 52:281-286.
11. Peroutka SJ. The pharmacology of current anti-migraine drugs. Headache. 1990; 30(suppl 1):5-11.
12. Pradalier A, Clapin A, Dry J. Treatment review: Nonsteroidal anti-inflammatory drugs in the treatment and long-term prevention of migraine attacks. Headache. 1988; 28:550-557.
13. Raskin NH, Schwartz RK. Interval therapy of migraine: Long-term results. Headache. 1980; 20:336-340.
14. Saper JR, Silberstein SD, Lake AE, Winters ME. Fluoxetine and migraine: Comparison in double-blind trial. Headache. 1995; 35:233.
15. Sargent JD. Prophylactic pharmacology for migraine. In: Treating the Headache Patient (Cady RK, Fox AW, eds). New York: Marcel Dekker; 1995; 179-191.
16. Spierings ELH. Clinical and experimental evidence for a role of calcium entry blockers in the treatment of migraine. Ann NY Acad Sci. 1988; 522:676-689.
17. Slang P, Osterhaus JT. Epidemiology of migraine. In: Treating the Headache Patient (Cady RK, Fox AW, eds). New York: Marcel Dekker; 1995; 41-60.
18. Tfelt-Hansen P. Efficacy of beta blockers in migraine: A critical review. Cephalalgia. 1986; 6(suppl 5):15-24.
19. Whitty CWM, Hockaday JM. Migraine: A follow-up study of 92 patients. Br Med J. 1968; 1:735-736.